Cargando…
Diabetic Nephropathy and Gaseous Modulators
Diabetic nephropathy (DN) remains the leading cause of vascular morbidity and mortality in diabetes patients. Despite the progress in understanding the diabetic disease process and advanced management of nephropathy, a number of patients still progress to end-stage renal disease (ESRD). The underlyi...
Autores principales: | Juin, Subir Kumar, Ouseph, Rosemary, Gondim, Dibson Dibe, Jala, Venkatakrishna Rao, Sen, Utpal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215699/ https://www.ncbi.nlm.nih.gov/pubmed/37237955 http://dx.doi.org/10.3390/antiox12051088 |
Ejemplares similares
-
GYY4137 Regulates Extracellular Matrix Turnover in the Diabetic Kidney by Modulating Retinoid X Receptor Signaling
por: Juin, Subir Kumar, et al.
Publicado: (2021) -
Glucosidase inhibitor, Nimbidiol ameliorates renal fibrosis and dysfunction in type-1 diabetes
por: Juin, Subir Kumar, et al.
Publicado: (2022) -
Temporal increase in the incidence of anal squamous cell carcinoma in Kentucky and factors associated with adverse outcomes
por: O'brien, Stephen J., et al.
Publicado: (2023) -
Regulation of Intestinal Barrier Function by Microbial Metabolites
por: Ghosh, Sweta, et al.
Publicado: (2021) -
Cytochrome P450 1A1 is essential for the microbial metabolite, Urolithin A-mediated protection against colitis
por: Ghosh, Sweta, et al.
Publicado: (2022)